Abstract
Recent developments in nanotechnology have paved the way for using quantum dots (QDs) in nanodiagnostics and nanotherapeutics. Careful design and preparation of QDs are guided by these application-specific requirements. QDs will probably be one of the first nanomaterial to reach clinical applications, however many challenges in this field have yet to be overcome. In this article, we present an extensive review of the pharmacokinetic properties of QDs. The representative studies responsible for observing quantitative determination of QDs biodistribution in vivo are presented. The effects of size, surface chemistry, and target moiety on their pharmacokinetics are discussed. Finally, future directions for improving the pharmacokinetics of QDs and perspectives in the field are discussed. The understanding of its absorption, distribution, metabolism, and excretion from the body will provide important guidelines for the successful clinical use of QDs.
Keywords: Quantum dots, pharmacokinetics, nanoparticles, preparation, quantification.
Current Drug Metabolism
Title:An Overview on the Pharmacokinetics of Quantum Dots
Volume: 14 Issue: 8
Author(s): Xianwei Meng, Li Qiang and Jianfei Wei
Affiliation:
Keywords: Quantum dots, pharmacokinetics, nanoparticles, preparation, quantification.
Abstract: Recent developments in nanotechnology have paved the way for using quantum dots (QDs) in nanodiagnostics and nanotherapeutics. Careful design and preparation of QDs are guided by these application-specific requirements. QDs will probably be one of the first nanomaterial to reach clinical applications, however many challenges in this field have yet to be overcome. In this article, we present an extensive review of the pharmacokinetic properties of QDs. The representative studies responsible for observing quantitative determination of QDs biodistribution in vivo are presented. The effects of size, surface chemistry, and target moiety on their pharmacokinetics are discussed. Finally, future directions for improving the pharmacokinetics of QDs and perspectives in the field are discussed. The understanding of its absorption, distribution, metabolism, and excretion from the body will provide important guidelines for the successful clinical use of QDs.
Export Options
About this article
Cite this article as:
Meng Xianwei, Qiang Li and Wei Jianfei, An Overview on the Pharmacokinetics of Quantum Dots, Current Drug Metabolism 2013; 14 (8) . https://dx.doi.org/10.2174/138920021131400103
DOI https://dx.doi.org/10.2174/138920021131400103 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
Call for Papers in Thematic Issues
Interaction between drugs and endocrine diseases
The introduction of highly active antiretroviral therapy accelerated studies and our understanding on the interaction between pharmacological therapies and endocrine diseases. Drugs can precipitate endocrine via different mechanisms, including direct alteration of hormone production and secretion, dysregulation of hormonal axis, effects on hormonal transport, receptor-binding, and cellular signalling. Common drug-induced ...read more
Tissue Distribution and Metabolism of Micro- and Nanoparticles and Medical Implants
With the continuous advancement of modern science and engineering, numerous functional materials and active molecules have been developed and utilized in various industrial, medical, and food applications. Many of these can enter the body, either actively or passively, and have significant and intricate impacts on human health. For example, biomaterials ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Diffuse Large B-Cell Lymphoma with Involvement of the Chest Wall
Current Respiratory Medicine Reviews Designing Proteins That Work Using Recombinant Technologies
Current Pharmaceutical Biotechnology Breast Cancer: Current Developments in Molecular Approaches to Diagnosis and Treatment
Recent Patents on Anti-Cancer Drug Discovery Harnessing the Tumor Suppressor Function of FOXO as an Alternative Therapeutic Approach in Cancer
Current Drug Targets circEPSTI1 Acts as a ceRNA to Regulate the Progression of Osteosarcoma
Current Cancer Drug Targets (Neuro)Transmitter Systems in Circulating Immune Cells: A Target of Immunopharmacological Interventions?
Current Medicinal Chemistry New Derivatives of BM212: A Class of Antimycobacterial Compounds Based on the Pyrrole Ring as a Scaffold
Mini-Reviews in Medicinal Chemistry Dendritoma Vaccine for Cancer: A Hopeful Approach
Current Cancer Therapy Reviews PDE-5 Inhibitors for BPH-Associated LUTS
Current Drug Targets Pharmacometrics of Stilbenes: Seguing Towards the Clinic
Current Clinical Pharmacology Motor Neuron Disease and Acquired Axonal Neuropathy Association in HIV Infection: Case Report and Update
Current HIV Research HSV Amplicons: Neuro Applications
Current Gene Therapy Mechanisms of Tubulin Binding Ligands to Target Cancer Cells: Updates on their Therapeutic Potential and Clinical Trials
Current Cancer Drug Targets Pathophysiogenesis of Mesial Temporal Lobe Epilepsy: Is Prevention of Damage Antiepileptogenic?
Current Medicinal Chemistry Genetic Variations in Telomere Maintenance, with Implications on Tissue Renewal Capacity and Chronic Disease Pathologies
Current Pharmacogenomics and Personalized Medicine Benzimidazole Derivatives as Kinase Inhibitors
Current Medicinal Chemistry Immunomodulation and Anti-inflammatory Roles of Polyphenols as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Removal of the Tag from His-tagged ILYd4, a Human CD59 Inhibitor, Significantly Improves its Physical Properties and its Activity
Current Pharmaceutical Design Combining Gene Therapy and Radiation Against Cancer
Current Gene Therapy Pharmacokinetic and Pharmacodynamic Relationship of Blinatumomab in Patients with Non-Hodgkin Lymphoma
Current Clinical Pharmacology